CAPTURA BIOPHARMA

captura-biopharma-logo

Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide contamination and heavy metal poisoning. Its lead chelation candidate, C2E2, will be the world's first oral treatment indicated for internal radiation contamination and has been proven in efficacy studies to target select heavy metals, notably americium, plutonium, and lead. Heavy metal contamination, including exposure to transuranic elements, is on the rise.

#SimilarOrganizations #People #Financial #Website #More

CAPTURA BIOPHARMA

Social Links:

Industry:
Biopharma Biotechnology Life Science

Founded:
2019-01-01

Address:
Little Rock, Arkansas, United States

Country:
United States

Website Url:
http://www.capturabiopharma.com

Total Employee:
1+

Status:
Active

Contact:
501-516-3905

Email Addresses:
[email protected]

Total Funding:
50 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Nginx


Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

demetrix-logo

Demetrix

Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

pilot-biotechnology-logo

Pilot Biotechnology

Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.

Current Employees Featured

not_available_image

Anthony Soscia
Anthony Soscia President, Co-Founder @ Captura Biopharma
President, Co-Founder
2019-02-01

michael-geranen_image

Michael Geranen
Michael Geranen Chief Executive Officer @ Captura Biopharma
Chief Executive Officer
2019-02-01

Founder


not_available_image

Anthony Soscia

michael-geranen_image

Michael Geranen

Investors List

the-global-emerging-markets-group_image

The Global Emerging Markets Group

The Global Emerging Markets Group investment in Venture Round - Captura Biopharma

Official Site Inspections

http://www.capturabiopharma.com

  • Host name: 255.209.73.34.bc.googleusercontent.com
  • IP address: 34.73.209.255
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Captura Biopharma"

Captura Biopharma - A Solution to Capturing Radioactive Heavy โ€ฆ

Captura Biopharma is developing an oral solution that can immediately be administered to eliminate harmful radioactive material from the body.See details»

Captura Biopharma - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 501-516-3905 Captura Biopharma is an biotechnology company engaged in the development and commercialization โ€ฆSee details»

About - Captura Biopharma

Captura Biopharma was founded by Michael Geranen and Anthony Soscia based on research performed at the University of North Carolina. Captura is located in Little Rock, AR and itโ€™s lead product, C2E2, has been funded by grants from โ€ฆSee details»

Captura Biopharma Company Profile | Management and โ€ฆ

Www.capturabiopharma.com . Captura Biopharma Profile and History. Captura Biopharma is developing an oral solution that can immediately be administered to eliminate harmful โ€ฆSee details»

Captura Biopharma, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Captura Biopharma, Inc. of Little Rock, AR. Get the latest business insights from Dun & Bradstreet.See details»

Captura Biopharma - PitchBook

Captura Biopharma General Information Description. Operator of a biotechnology company engaged in the development of IV chelation drugs. The company offers drugs for the treatment โ€ฆSee details»

Captura Biopharma - LinkedIn

Captura Biopharma Pharmaceutical Manufacturing Little Rock, Arkansas 191 followers Captura Biopharma: Our Solution is THE Solution!See details»

The Captura Team - Captura Biopharma

Dr. Gary Barnette Ph.D., Regulatory. Dr. Barnette was Sr. Vice President of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services, LLC from 2012 to August 2018 and โ€ฆSee details»

Captura Biopharma, Inc. in Little Rock, AR - (501) 516-3905 - Profile

Captura Biopharma, Inc. is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»

Captura Biopharma - Crustdata Company Profile, Funding and โ€ฆ

Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide โ€ฆSee details»

Captura Biopharma - Company Profile - Tracxn

Feb 8, 2025 Captura Biopharma - Developer of therapeutic to eliminate harmful radioactive material from the body. Acquired by OceanTech Acquisitions. Raised funding over 1 round โ€ฆSee details»

Captura Biopharma - Overview, News & Similar companies

Www.capturabiopharma.com. Revenue <$5 Million. Industry Drug Manufacturing & Research Pharmaceuticals Healthcare . Recent News & Media. OceanTech Acquisitions I Corp. โ€ฆSee details»

Captura Biopharma - Products, Competitors, Financials, Employees ...

Captura Biopharma is a biotechnology company developing an oral solution that can immediately be administered to eliminate harmful radioactive material from the body. Use the CB Insights โ€ฆSee details»

Captura Biopharma LLC - discovery.patsnap.com

Captura Biopharma is a company that provides Biology, Biotechnology and more. Captura Biopharma is headquartered in United States Arkansas. Captura Biopharma was founded in โ€ฆSee details»

Background - Captura Biopharma

Captura Biopharmaโ€™s proposed product, C2E2, is a diethyl ester of DTPA, which has been shown to be orally bioavailable and to chelate the transuranic radionuclide americium (241Am) in โ€ฆSee details»

Captura Biopharma Secures $50 Million Investment Commitment โ€ฆ

Aug 18, 2021 Captura Biopharma Secures $50 Million Investment Commitment from GEM as Company Seeks to Go Public in Coming Months The Company plans to go public in the โ€ฆSee details»

Captura Biopharma Secures $50 Million Investment ... - Markets โ€ฆ

Aug 18, 2021 Contact: [email protected] . Press Contact: Steve Smith 501-547-7502 View original content: ...See details»

Project Status - Captura Biopharma

IND-enabling tasks have been completed for C2E2, Captureโ€™s lead development candidate, including pre-formulation characterization of the drug molecule, extensive safety-toxicology โ€ฆSee details»

Captura BioPharma - Matmon Internet Inc.

The Captura Biopharma website needs to convey a lot of information, and the old site lacked organization and readability. The new design reorders information into digestible facts and โ€ฆSee details»

The Solution - Captura Biopharma

Ca-DTPA (trisodium calcium diethylenetriaminepentaacetate) and Zn-DTPA (trisodium zinc diethylenetriaminepentaacetate) have been used extensively for over forty years as โ€ฆSee details»

linkstock.net © 2022. All rights reserved